The Methodist Hospital
10 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 4 name spellings.
0
Ending by 2030
Oct 2032
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Mar 17 to 24, 2027 · next Mar 17
- 1 fee due May 14, 2027The maintenance fee for Method and apparatus for the fail-safe termination of in vivo drug delivery from an implantable drug delivery system (US 11,813,432) comes due May 14, 2027. Unpaid by Nov 15, 2027, it lapses early.
- 1 fee due Jun 10, 2027The maintenance fee for Method and Apparatus for Providing Transcranial Magnetic Stimulation (TMS) to a Patient (US 10,500,408) comes due Jun 10, 2027. Unpaid by Dec 10, 2027, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for Chemotherapeutic compositions and methods for treating human gliomas (US 10,555,936) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
- 1 fee due Oct 23, 2027The maintenance fee for Systems and methods for computer-aided orthognathic surgical planning (US 11,963,832) comes due Oct 23, 2027. Unpaid by Apr 24, 2028, it lapses early.
Recent changes
- 2 of the patents on this record were granted since Aug 18, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,555,936 | Chemotherapeutic compositions and methods for treating human gliomas In force · From the USPTO record | In force | From the USPTO record | |
| US 11,291,853 | Method and Apparatus for Providing Transcranial Magnetic Stimulation (TMS) to a Patient In force · High confidence | In force | High confidence | |
| US 10,500,408 | Method and Apparatus for Providing Transcranial Magnetic Stimulation (TMS) to a Patient In force · Medium confidence | In force | Medium confidence | |
| US 9,456,784 | Method and Apparatus for Providing Transcranial Magnetic Stimulation (TMS) to a Patient In force · High confidence | In force | High confidence | |
| US 10,130,713 | Cocrystalline DHEA Formulations In force · High confidence | In force | High confidence | |
| US D856,517 | Asymmetric Tissue Graft In force · High confidence | In force | High confidence | |
| US 10,722,129 | Imaging System for Intra-Operative and Post-Operative Blood Perfusion Monitoring In force · High confidence | In force | High confidence | |
| US 10,420,838 | Methods for Treating Cancer Using Inos-Inhibitory Compositions In force · Medium confidence | In force | Medium confidence | |
| US 11,357,850 | Methods for Treating Breast Cancer Using Inos-Inhibitory Compositions In force · Medium confidence | In force | Medium confidence | |
| US 10,413,209 | Method and apparatus for identifying the ureter during a minimally-invasive procedure In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 37: 10 patents in force now held by others · 12 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
22 pending · 12 abandoned · 32 no status recorded